CI Investments Inc
XENE icon

CI Investments Inc’s Xenon Pharmaceuticals XENE Stock Holding History

CI Investments Inc’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,705
Closed -$3.08M – 1428
2022
Q1 		$3.08M Buy
+100,705
New +$3.01M 0.01% 354

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CI Investments Inc's XENE Position: Q2 2022 in Review

CI Investments Inc sold out of Xenon Pharmaceuticals (XENE) in Q2 2022, closing a stake of 100,705 shares — an estimated $3.08M sold.

CI Investments Inc first reported a position in XENE in Q1 2022 and held it in 1 quarter. The position peaked at $3.08M in Q1 2022. 151 funds tracked by Wall St. Rank hold XENE as of Q2 2022.

  • CI Investments Inc reported no remaining Xenon Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • CI Investments Inc sold 100,705 Xenon Pharmaceuticals shares in Q2 2022, an estimated $3.08M.
  • CI Investments Inc first reported a position in Xenon Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • CI Investments Inc's Xenon Pharmaceuticals position peaked at $3.08M in Q1 2022.
  • 151 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.